News
Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...
Researchers have created liver tissue that grows its own blood vessels, improving research into hemophilia and liver damage.
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
US President Donald Trump’s plan to drop a 200 per cent tariff bomb on Australian pharmaceuticals is set to “screw over” the ...
CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...
Hemlibra safely reduces bleeding episodes in people with hemophilia A without inhibitors, per a review study that confirmed ...
Anderson Cooper has one foot out the door at CNN, according to sources who tell the National Enquirer that the newsman’s ...
In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- ...
5d
24/7 Wall St. on MSNStocks At All-Time Highs - Grab Your Gains and Buy These 7% Dividend GemsThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
1d
24/7 Wall St. on MSNWill The Tariff "Taco Trade" End The Rally? 5 High-Yield Value Stocks Are Strong Buys NowThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results